| __timestamp | Iovance Biotherapeutics, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 22746000000 |
| Thursday, January 1, 2015 | 999000 | 21536000000 |
| Friday, January 1, 2016 | 978000 | 21685000000 |
| Sunday, January 1, 2017 | 952000 | 25354000000 |
| Monday, January 1, 2018 | 956000 | 27091000000 |
| Tuesday, January 1, 2019 | 8122999 | 27556000000 |
| Wednesday, January 1, 2020 | 8712000 | 28427000000 |
| Friday, January 1, 2021 | 13980000 | 23402000000 |
| Saturday, January 1, 2022 | 21135000 | 24596000000 |
| Sunday, January 1, 2023 | 10755000 | 26553000000 |
| Monday, January 1, 2024 | 27471000000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical industry, understanding cost structures is crucial. This analysis delves into the cost of revenue for two industry players: Johnson & Johnson and Iovance Biotherapeutics, Inc., from 2014 to 2023.
Johnson & Johnson, a titan in the healthcare sector, consistently reported a cost of revenue exceeding $20 billion annually. Notably, their costs peaked in 2020, reflecting a 32% increase from 2014. In contrast, Iovance Biotherapeutics, a burgeoning biotech firm, exhibited a more volatile cost pattern. Their expenses surged by over 100% from 2014 to 2022, highlighting their aggressive growth strategy.
This decade-long comparison underscores the stark differences in scale and strategy between established giants and emerging innovators. As the industry continues to evolve, these insights provide a window into the financial dynamics shaping the future of healthcare.
Cost of Revenue Comparison: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Johnson & Johnson vs Viatris Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Viatris Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: PTC Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Celldex Therapeutics, Inc.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Evotec SE